New Huntington's drug shows promise in small safety study
Disease control
Completed
This early study tested a new drug called ER2001 in 10 adults with early Huntington's disease. The main goal was to check if the drug is safe and how the body processes it. Participants received increasing doses over 14 weeks. Researchers also looked for early signs that the drug…
Phase: EARLY_PHASE1 • Sponsor: ExoRNA Bioscience • Aim: Disease control
Last updated May 04, 2026 16:30 UTC